The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo

Influenza A virus (IAV) is a common pathogen of respiratory disease. The IAV-induced seasonal epidemics and the sporadic pandemics are associated with high morbidity and mortality. Therefore, effective protection and therapy for IAV infections is an important challenge in countering this public heal...

詳細記述

書誌詳細

主要な著者:	Sebastian Schloer, Jonas Goretzko, Alexander Kühnl, Linda Brunotte, Stephan Ludwig, Ursula Rescher
フォーマット:	Artigo
言語:	Inglês
出版事項:	Taylor & Francis Group 2019-01-01
シリーズ:	Emerging Microbes and Infections
主題:	Influenza A virus posaconazole itraconazole interferon response cellular cholesterol host cell factors
オンライン･アクセス:	https://www.tandfonline.com/doi/10.1080/22221751.2018.1559709
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!